(Total Views: 528)
Posted On: 03/10/2021 1:11:43 PM
Post# of 154001
Ohm/TechGuru/others....
What do you make of the severe population that didn't get SOC or Dex, ~80 patients, which seemed to be the weak point for CD12?
I guess I'm having a hard time understanding who this population is. Were they ineligible for SOC/Dex for some reason? Or perhaps just not actually in that bad of shape?
Why did LL show benefit in the CD10 Moderate population, and CD12 critical population, but struggle in this group? Any theories would be helpful.
What do you make of the severe population that didn't get SOC or Dex, ~80 patients, which seemed to be the weak point for CD12?
I guess I'm having a hard time understanding who this population is. Were they ineligible for SOC/Dex for some reason? Or perhaps just not actually in that bad of shape?
Why did LL show benefit in the CD10 Moderate population, and CD12 critical population, but struggle in this group? Any theories would be helpful.
(4)
(0)
